Pralsetinib + Cyp3a Inducers Interaction
Majorinteraction on record
Description
Concomitant use decreases pralsetinib exposure, which may decrease efficacy of GAVRETO. Avoid coadministration; if unavoidable, increase GAVRETO dose.
Mechanism
CYP3A induction decreases pralsetinib exposure
Source: NLP:pralsetinib